Role of Osteocytes in Myeloma Bone Disease
骨细胞在骨髓瘤骨病中的作用
基本信息
- 批准号:8736266
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAffectAffinityAfrican AmericanAgeAnimalsAutomobile DrivingBindingBiological AssayBiologyBone DiseasesBone MatrixBone PainBone ResorptionBone neoplasmsBortezomibBreastCalvariaCell Culture TechniquesCell LineCellsCessation of lifeClinicClinicalClinical TrialsDataDiagnosisEndocrineEnzymesEtiologyExperimental ModelsFibroblast Growth Factor ReceptorsFractureFutureGene TargetingGenesGenetic TranscriptionGrowthGrowth FactorHepatocyte Growth FactorHomingHormone ReceptorHormonesHumanIncidenceIndividualLaboratoriesLifeLuciferasesMalignant Bone NeoplasmMalignant NeoplasmsMalignant neoplasm of lungMediator of activation proteinMessenger RNAMetastatic Neoplasm to the BoneMolecularMorbidity - disease rateMultiple MyelomaMusMyeloma ProteinsNewly DiagnosedOrgan Culture TechniquesOsteoblastsOsteoclastsOsteocytesOsteogenesisOsteolysisOsteolyticPainPathologyPathway interactionsPatientsPharmaceutical PreparationsPlasma CellsPopulationProductionProstateProteasome InhibitorRecombinant Fibroblast Growth FactorRegulationResearch PersonnelRoleSamplingSerumSkeletonSourceTNFSF11 geneTRANCE proteinTestingTimeTreatment CostWorkanimal painbasebonecancer typecell typecostfibroblast growth factor 23heparanaseimprovedinhibitor/antagonistinterestmortalitymouse modeloutcome forecastpatient populationpromoterpublic health relevancereceptorresearch studyresponsesyndecantranscription factortumortumor growth
项目摘要
DESCRIPTION (provided by applicant):
Project Summary Multiple myeloma (MM) grows in and attacks the skeleton, causing pain and bone-related pathologies, such as fracture, as well as contributing to death. Many interactions between the tumor and the bone microenvironment are understood, but none involves pathways unique to bone, and myeloma bone disease (MBD) remains largely incurable. We asked whether factors made only by bone acted specifically on myeloma cells. MM cells, both laboratory cell lines and from patients, expressed the receptor for the hormone fibroblast growth factor (FGF)-23, which is made by osteocytes, abundant cells in bone. In newly diagnosed patients, intact serum FGF23 was 3X higher in MM than in controls. Recombinant FGF23 increased heparanase mRNA 5-18x in 2 MM cell lines at 24hrs. Heparanase is a secreted enzyme that enhances tumor homing and growth in bone and is a marker of poor MM prognosis. It increases bone destruction via the factor RANK ligand and suppresses bone formation, releases growth factors from bone matrix and modifies the MM protein syndecan-1. We propose a new vicious cycle of myeloma bone disease: A) MM cells stimulate osteocytes to secrete FGF23; B) FGF23 increases heparanase expression by MM cells; C) Heparanase alters the bone microenvironment and increases RANK ligand, Dkk1, osteolysis & tumor growth; D) Heparanase increases hepatocyte growth factor (HGF) in bone, which additionally stimulates MM cells; E) FGF23 may enhance MM adhesion to bone. The two Investigators combine extensive individual interests in cancer:bone molecular interactions (JMC) and the biology of clinical myeloma (AS) with a shared interest in the etiology and improved treatment of myeloma bone disease. We propose Four Specific Aims: 1: Determine the cellular pathways by which MM increases FGF23, including testing if known factors made by MM cells regulate FGF23 production, or if it is regulated by heparanase, HGF or the approved MM treatment bortezomib. 2: Determine the role of circulating FGF23 in MM patients, asking if FGF23 & heparanase concentrations are correlated in MM patients and testing if MM cells from patients increase bone release of FGF23. 3: Determine the importance of FGF23-increased heparanase in MBD. 4. Determine molecular mechanisms that control heparanase expression in the bone microenvironment. The project uses a new experimental model of myeloma:bone interactions. In EVOCA (ex vivo organ culture assay), human MM cells are cultured on mouse bone, which supports growth of cell lines and patient samples (which dramatically increase FGF23 in bone). We will make MM cell lines with promoters driving secreted luciferases to analyze changes in gene activity over time in the tumor:bone microenvironment. Experiments with live animal are avoided, lowering costs & increasing efficiency, along with elimination of animal pain & suffering. EVOCA enables new studies in Aim 2 with primary samples to test the importance of the FGF23:heparanase vicious cycle in MBD in individual patients. Inhibitors of FGF23 & heparanase are in clinical trials. Our studies will guide their future application to the treatmentof myeloma bone disease and other cancer bone metastases.
描述(由申请人提供):
项目摘要 多发性骨髓瘤 (MM) 在骨骼中生长并侵袭骨骼,导致疼痛和与骨骼相关的病变,例如骨折,并导致死亡。肿瘤与骨微环境之间的许多相互作用已被了解,但没有一个涉及骨特有的途径,并且骨髓瘤骨病(MBD)在很大程度上仍然无法治愈。我们询问仅由骨骼产生的因子是否专门作用于骨髓瘤细胞。 MM 细胞(包括实验室细胞系和患者细胞)表达激素成纤维细胞生长因子 (FGF)-23 的受体,该受体由骨细胞(骨中丰富的细胞)产生。在新诊断的 MM 患者中,完整血清 FGF23 比对照组高 3 倍。 24 小时后,重组 FGF23 将 2 个 MM 细胞系中的乙酰肝素酶 mRNA 增加了 5-18 倍。乙酰肝素酶是一种分泌酶,可增强肿瘤在骨中的归巢和生长,是 MM 预后不良的标志。它通过因子 RANK 配体增加骨破坏并抑制骨形成,从骨基质中释放生长因子并修饰 MM 蛋白 syndecan-1。我们提出了骨髓瘤骨病的新恶性循环:A)MM细胞刺激骨细胞分泌FGF23; B) FGF23 增加 MM 细胞的乙酰肝素酶表达; C) 乙酰肝素酶改变骨微环境并增加 RANK 配体、Dkk1、骨质溶解和肿瘤生长; D) 乙酰肝素酶会增加骨骼中的肝细胞生长因子 (HGF),从而进一步刺激 MM 细胞; E) FGF23 可以增强 MM 对骨的粘附。两位研究人员将个人对癌症:骨分子相互作用 (JMC) 和临床骨髓瘤 (AS) 生物学的广泛兴趣与对骨髓瘤骨病的病因学和改进治疗的共同兴趣结合起来。我们提出四个具体目标: 1:确定 MM 增加 FGF23 的细胞途径,包括测试 MM 细胞产生的已知因子是否调节 FGF23 的产生,或者它是否受到乙酰肝素酶、HGF 或已批准的 MM 治疗硼替佐米的调节。图2:确定循环FGF23在MM患者中的作用,询问MM患者中的FGF23和乙酰肝素酶浓度是否相关,并测试来自患者的MM细胞是否增加FGF23的骨释放。图 3:确定 FGF23 增加的乙酰肝素酶在 MBD 中的重要性。 4. 确定控制骨微环境中乙酰肝素酶表达的分子机制。该项目使用骨髓瘤:骨相互作用的新实验模型。在 EVOCA(离体器官培养测定)中,人类 MM 细胞在小鼠骨骼上培养,支持细胞系和患者样本的生长(这会显着增加骨骼中的 FGF23)。我们将制作带有驱动分泌荧光素酶的启动子的 MM 细胞系,以分析肿瘤:骨微环境中基因活性随时间的变化。避免使用活体动物进行实验,从而降低成本并提高效率,同时消除动物的疼痛和痛苦。 EVOCA 能够利用原始样本进行 Aim 2 中的新研究,以测试 FGF23:乙酰肝素酶恶性循环在个体患者 MBD 中的重要性。 FGF23 和乙酰肝素酶抑制剂正在进行临床试验。我们的研究将指导它们未来在治疗骨髓瘤骨病和其他癌症骨转移中的应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN M CHIRGWIN其他文献
JOHN M CHIRGWIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN M CHIRGWIN', 18)}}的其他基金
Manipulating the N-end Rule Protein Degradation Pathway to Build Bone and Decrease Tumor Growth in Multiple Myeloma Bone Disease
操纵 N 端规则蛋白降解途径来构建骨并减少多发性骨髓瘤骨病中的肿瘤生长
- 批准号:
10582710 - 财政年份:2020
- 资助金额:
-- - 项目类别:
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
一种抑制骨肿瘤生长、防止恶病质肌肉损失并保持骨骼完整性的新型药物
- 批准号:
10158431 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
一种抑制骨肿瘤生长、防止恶病质肌肉损失并保持骨骼完整性的新型药物
- 批准号:
10454796 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
一种抑制骨肿瘤生长、防止恶病质肌肉损失并保持骨骼完整性的新型药物
- 批准号:
9912632 - 财政年份:2019
- 资助金额:
-- - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship














{{item.name}}会员




